CN114794330A - 一种调节水生动物活力状态的功能性调理剂及其制备方法 - Google Patents
一种调节水生动物活力状态的功能性调理剂及其制备方法 Download PDFInfo
- Publication number
- CN114794330A CN114794330A CN202210356786.5A CN202210356786A CN114794330A CN 114794330 A CN114794330 A CN 114794330A CN 202210356786 A CN202210356786 A CN 202210356786A CN 114794330 A CN114794330 A CN 114794330A
- Authority
- CN
- China
- Prior art keywords
- vitality
- regulating
- group
- taurine
- caffeine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 26
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 49
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 44
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 26
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 26
- 239000011720 vitamin B Substances 0.000 claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 25
- 229960003080 taurine Drugs 0.000 claims abstract description 24
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960001948 caffeine Drugs 0.000 claims abstract description 22
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 22
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims abstract description 22
- 235000019136 lipoic acid Nutrition 0.000 claims abstract description 22
- 229960002663 thioctic acid Drugs 0.000 claims abstract description 22
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 21
- 229940024606 amino acid Drugs 0.000 claims abstract description 21
- 150000001413 amino acids Chemical class 0.000 claims abstract description 21
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 21
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 21
- 239000001168 astaxanthin Substances 0.000 claims abstract description 21
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 21
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 21
- 229960005375 lutein Drugs 0.000 claims abstract description 21
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 21
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 21
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 20
- 239000004410 anthocyanin Substances 0.000 claims abstract description 20
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 20
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 20
- 235000012680 lutein Nutrition 0.000 claims abstract description 20
- 239000001656 lutein Substances 0.000 claims abstract description 20
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 20
- 238000003756 stirring Methods 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 230000037208 balanced nutrition Effects 0.000 abstract description 3
- 235000019046 balanced nutrition Nutrition 0.000 abstract description 3
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- 229930091051 Arenine Natural products 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000000627 niacin group Chemical group 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Obesity (AREA)
- Birds (AREA)
- Insects & Arthropods (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种调节水生动物活力状态的功能性调理剂及其制备方法,包括以下重量份的组分:液态维生素B族40‑60克,牛磺酸5‑15克,氨基酸5‑15克、咖啡因2‑8克、叶黄素2‑6克、花青素2‑7克、虾青素2‑8克、硫辛酸5‑15克。其制备方法,具体如下:将上述重量份的液态维生素B族,牛磺酸,氨基酸、咖啡因、叶黄素、花青素、虾青素、硫辛酸混合在一起,再进行搅拌均匀,搅拌温度为30‑50℃,搅拌时间为30分钟。本发明采用合理的配方,使得液态维生素B族发挥最大的作用,从而使得本产品营养全面、均衡,抗氧化能力强、调活力快。
Description
技术领域
本发明涉及的是功能性维生素营养保健调理剂技术领域,具体涉及一种调节水生动物活力状态的功能性调理剂及其制备方法。
背景技术
目前市面上用于调节水生动物活力状态的营养保健调理剂种类繁多,但是大部分营养不够全面,不能有效地提高水生动物活力状态,为了解决上述问题,本发明设计了一种调节水生动物活力状态的功能性维生素营养保健调理剂及其制备方法。
发明内容
针对现有技术上存在的不足,本发明目的是在于提供一种调节水生动物活力状态的功能性调理剂及其制备方法,通过独特、合理配方,使得液态维生素B族发挥最大的作用,从而使得本产品营养全面、均衡,抗氧化能力强、调活力快。
为了实现上述目的,本发明是通过如下的技术方案来实现:一种调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族40-60克,牛磺酸5-15克,氨基酸5-15克、咖啡因2-8克、叶黄素2-6克、花青素2-7克、虾青素2-8克、硫辛酸5-15克。
作为优选,所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族40克,牛磺酸5克,氨基酸5克、咖啡因2克、叶黄素2克、花青素2克、虾青素2克、硫辛酸5克。
作为优选,所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族60克,牛磺酸15克,氨基酸15克、咖啡因8克、叶黄素6克、花青素7克、虾青素85克、硫辛酸15克。
作为优选,所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族50克,牛磺酸10克,氨基酸10克、咖啡因5克、叶黄素5克、花青素5克、虾青素5克、硫辛酸10克。
一种调节水生动物活力状态的功能性调理剂的制备方法,具体如下:将上述重量份的液态维生素B族,牛磺酸,氨基酸、咖啡因、叶黄素、花青素、虾青素、硫辛酸混合在一起,再进行搅拌均匀,搅拌温度为30-50℃,搅拌时间为30分钟。
本发明的有益效果:本发明采用合理的配方,使得液态维生素B族发挥最大的作用,从而使得本产品营养全面、均衡,抗氧化能力强、调活力快。
具体实施方式
为使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体实施方式,进一步阐述本发明。
本具体实施方式采用以下技术方案:一种调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族40-60克,牛磺酸5-15克,氨基酸5-15克、咖啡因2-8克、叶黄素2-6克、花青素2-7克、虾青素2-8克、硫辛酸5-15克。
一种调节水生动物活力状态的功能性调理剂的制备方法,具体如下:将上述重量份的液态维生素B族,牛磺酸,氨基酸、咖啡因、叶黄素、花青素、虾青素、硫辛酸混合在一起,再进行搅拌均匀,搅拌温度为30-50℃,搅拌时间为30分钟。
本具体实施方式中的液态维生素B族主要有维生素B1(硫胺素、抗脚气病维生素)、维生素B2(核黄素)、维生素PP(尼克酸或烟酸、抗癞皮病维生素)、维生素B6(吡哆醇、抗皮炎维生素),泛酸(遍多酸)、生物素、叶酸、维生素B12(钴胺素、抗而性贫血维生素).维生素B族有十二种以上,被世界一致公认的人体必需维生素有九种,全是水溶性维生素,在体内滞留的时间只有数小时,必须每天补充。B族是所有人体组织必不可少的营养素,是食物释放能量的关键。全是辅酶,参与体内糖、蛋白质和脂肪的代谢,因此被列为一个家族。
牛磺酸的化学结构式为H2N-CH2-CH2-SO3H,化学名称为β-氨基乙磺酸或2-氨基乙磺酸,相对分子质量为125.15,单斜棱形棒状白色晶体,熔点305.11℃,无毒、无臭、味微酸、对热稳定。牛磺酸可溶于水,12℃时溶解度为0.5%,其水溶液pH为4.1-5.6,在95%乙醇中17℃时溶解度为0.004%,不溶于无水乙醇、乙醚和丙酮。牛磺酸是一种有机渗透的调节物质,其不仅参与调节细胞体积,还为胆汁盐的形成提供基础,在细胞内游离钙浓度的调制方面也起到了重要作用。
氨基酸,是构成动物营养所需蛋白质的基本物质。
咖啡因是一种植物生物碱,在许多植物中都能够被发现。作为自然杀虫剂,它能使吞食含咖啡因植物的昆虫麻痹.
叶黄素具有较强的抗氧化能力,能够抑制氧自由基的活性,阻止氧自由基对正常细胞的破坏
花青素不但可作为营养强化剂,而且还可作为食品防腐剂代替苯甲酸等合成防腐剂
虾青素是一种断链抗氧化剂。具有极强的抗氧化能力,可以清除二氧化氮、硫化物、二硫化物等,也可降低脂质过氧化作用,有效的抑制自由基引起的脂质过氧化作用。同时,有抑制肿瘤发生,增强免疫力,清除体内自由基等多方面的生理作用,
硫辛酸是一种有机化合物,可作为辅酶参与机体内的物质代谢中的酰基转移,能消除导致加速老化与致病的自由基。硫辛酸在体内经肠道吸收后进入细胞,兼具脂溶性与水溶性的特性。
本具体实施方式通过独特合理配方,使得液态维生素B族发挥最大的作用,从而使得本调理剂营养全面、均衡,抗氧化能力强、调活力快。
实施例1:所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族40克,牛磺酸5克,氨基酸5克、咖啡因2克、叶黄素2克、花青素2克、虾青素2克、硫辛酸5克。
一种调节水生动物活力状态的功能性调理剂的制备方法,具体如下:将上述重量份的液态维生素B族,牛磺酸,氨基酸、咖啡因、叶黄素、花青素、虾青素、硫辛酸混合在一起,再进行搅拌均匀,搅拌温度为30℃,搅拌时间为30分钟。
实施例2:所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族60克,牛磺酸15克,氨基酸15克、咖啡因8克、叶黄素6克、花青素7克、虾青素85克、硫辛酸15克。
一种调节水生动物活力状态的功能性调理剂的制备方法,具体如下:将上述重量份的液态维生素B族,牛磺酸,氨基酸、咖啡因、叶黄素、花青素、虾青素、硫辛酸混合在一起,再进行搅拌均匀,搅拌温度为40℃,搅拌时间为30分钟。
实施例3:所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族50克,牛磺酸10克,氨基酸10克、咖啡因5克、叶黄素5克、花青素5克、虾青素5克、硫辛酸10克。
一种调节水生动物活力状态的功能性调理剂的制备方法,具体如下:将上述重量份的液态维生素B族,牛磺酸,氨基酸、咖啡因、叶黄素、花青素、虾青素、硫辛酸混合在一起,再进行搅拌均匀,搅拌温度为50℃,搅拌时间为30分钟。
以上显示和描述了本发明的基本原理和主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (5)
1.一种调节水生动物活力状态的功能性调理剂,其特征在于,包括以下重量份的组分:液态维生素B族40-60克,牛磺酸5-15克,氨基酸5-15克、咖啡因2-8克、叶黄素2-6克、花青素2-7克、虾青素2-8克、硫辛酸5-15克。
2.根据权利要求1所述的一种调节水生动物活力状态的功能性调理剂,其特征在于,所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族40克,牛磺酸5克,氨基酸5克、咖啡因2克、叶黄素2克、花青素2克、虾青素2克、硫辛酸5克。
3.根据权利要求1所述的一种调节水生动物活力状态的功能性调理剂,其特征在于,所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族60克,牛磺酸15克,氨基酸15克、咖啡因8克、叶黄素6克、花青素7克、虾青素85克、硫辛酸15克。
4.根据权利要求1所述的一种调节水生动物活力状态的功能性调理剂,其特征在于,所述的调节水生动物活力状态的功能性调理剂,包括以下重量份的组分:液态维生素B族50克,牛磺酸10克,氨基酸10克、咖啡因5克、叶黄素5克、花青素5克、虾青素5克、硫辛酸10克。
5.一种调节水生动物活力状态的功能性调理剂的制备方法,其特征在于,具体如下:将上述重量份的液态维生素B族,牛磺酸,氨基酸、咖啡因、叶黄素、花青素、虾青素、硫辛酸混合在一起,再进行搅拌均匀,搅拌温度为30-50℃,搅拌时间为30分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210356786.5A CN114794330A (zh) | 2022-04-06 | 2022-04-06 | 一种调节水生动物活力状态的功能性调理剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210356786.5A CN114794330A (zh) | 2022-04-06 | 2022-04-06 | 一种调节水生动物活力状态的功能性调理剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114794330A true CN114794330A (zh) | 2022-07-29 |
Family
ID=82532997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210356786.5A Pending CN114794330A (zh) | 2022-04-06 | 2022-04-06 | 一种调节水生动物活力状态的功能性调理剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114794330A (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101057856A (zh) * | 2007-05-09 | 2007-10-24 | 中国水产科学研究院淡水渔业研究中心 | 一种水产养殖用苗种活力快速恢复剂 |
CN104206827A (zh) * | 2014-08-05 | 2014-12-17 | 朱婷婷 | 鱼用饲料添加剂 |
CN104621409A (zh) * | 2015-02-13 | 2015-05-20 | 福建乐普生生物科技有限公司 | 一种大黄鱼饵料的专用添加剂 |
CN105105147A (zh) * | 2015-09-22 | 2015-12-02 | 哈尔滨宝德生物技术股份有限公司 | 富含叶黄素和虾青素的营养保健补充剂及制备方法 |
CN106551187A (zh) * | 2016-11-24 | 2017-04-05 | 佛山市南海东方澳龙制药有限公司 | 提高对虾抗应激反应的添加剂、饲料 |
CN106962683A (zh) * | 2017-04-12 | 2017-07-21 | 广州格雷特生物科技有限公司 | 一种养殖水产品专用营养强化液及其制备方法 |
CN110089633A (zh) * | 2019-05-17 | 2019-08-06 | 广东粤晋然生物科技有限公司 | 一种水产品生长速度调节剂 |
CN112790294A (zh) * | 2020-12-31 | 2021-05-14 | 广州爱保农饲料有限公司 | 一种水生动物专用维生素饲料添加剂及其应用 |
-
2022
- 2022-04-06 CN CN202210356786.5A patent/CN114794330A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101057856A (zh) * | 2007-05-09 | 2007-10-24 | 中国水产科学研究院淡水渔业研究中心 | 一种水产养殖用苗种活力快速恢复剂 |
CN104206827A (zh) * | 2014-08-05 | 2014-12-17 | 朱婷婷 | 鱼用饲料添加剂 |
CN104621409A (zh) * | 2015-02-13 | 2015-05-20 | 福建乐普生生物科技有限公司 | 一种大黄鱼饵料的专用添加剂 |
CN105105147A (zh) * | 2015-09-22 | 2015-12-02 | 哈尔滨宝德生物技术股份有限公司 | 富含叶黄素和虾青素的营养保健补充剂及制备方法 |
CN106551187A (zh) * | 2016-11-24 | 2017-04-05 | 佛山市南海东方澳龙制药有限公司 | 提高对虾抗应激反应的添加剂、饲料 |
CN106962683A (zh) * | 2017-04-12 | 2017-07-21 | 广州格雷特生物科技有限公司 | 一种养殖水产品专用营养强化液及其制备方法 |
CN110089633A (zh) * | 2019-05-17 | 2019-08-06 | 广东粤晋然生物科技有限公司 | 一种水产品生长速度调节剂 |
CN112790294A (zh) * | 2020-12-31 | 2021-05-14 | 广州爱保农饲料有限公司 | 一种水生动物专用维生素饲料添加剂及其应用 |
Non-Patent Citations (1)
Title |
---|
王成章等, 中国农业出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL193615C (nl) | Mengzout van een glucosaminesulfaat, werkwijze ter bereiding daarvan en farmaceutisch preparaat dat dit mengzout bevat. | |
Zhan et al. | Effects of different selenium source on selenium distribution, loin quality and antioxidant status in finishing pigs | |
Kuricova et al. | Chicken selenium status when fed a diet supplemented with Se-yeast | |
CN101132786B (zh) | 胍基乙酸的盐、加成化合物和络合化合物 | |
RU2421017C2 (ru) | Композиции и способы, стимулирующие потерю жировой массы | |
CN114794330A (zh) | 一种调节水生动物活力状态的功能性调理剂及其制备方法 | |
KR101034737B1 (ko) | 셀레노-아미노산 유도체 | |
Gatel et al. | Total amino acid requirements of weaned piglets 8 to 25 kg live weight given diets based on wheat and soya-bean meal fortified with free amino acids | |
CN104719631A (zh) | 海水工业化养殖大西洋鲑专用维生素营养剂及其制备方法 | |
CN105884637B (zh) | γ‑氨基丁酸富马酸盐及其在制备动物用饲料添加剂中的应用 | |
CN103053807B (zh) | 一种水溶性复合维生素制剂及其制备方法 | |
RU2277800C1 (ru) | Микроэлементный препарат для животных | |
US20220079979A1 (en) | Aqueous composition for livestock animals | |
Jeevanandam et al. | Nutritional efficacy of a spermidine supplemented diet | |
CN100508984C (zh) | 水产用维生素组合物 | |
CN113100351A (zh) | 一种饲料添加剂及其应用、一种用于缓解蛋鸡卵巢衰老的复方饲料 | |
CN111602750A (zh) | 一种新型蛋鸡沙棘饲料的制备方法 | |
KR101639336B1 (ko) | 반추가축 사료용 첨가제의 제조방법 | |
RU2425674C2 (ru) | Комплексный фармацевтический препарат | |
CN100534441C (zh) | 一种水产养殖用苗种活力快速恢复剂 | |
KR20050052366A (ko) | 유기태 금속이 축적된 미생물 제제 및 이의 제조 방법 | |
RU2555005C2 (ru) | Энергометаболический состав для стимуляции обменных процессов, профилактики гипомикроэлементозов и диареи поросят | |
RU2392829C1 (ru) | Селенсодержащая кормовая добавка "цеохол-se" для крупного рогатого скота | |
RU2646885C1 (ru) | Олигопептидная композиция | |
WO2017008902A1 (de) | Cholecalciferolsulfat-salze und deren verwendung zur behandlung von vitamin d3-mangel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220729 |